FDA Considering Independent Evaluation for DNA Contamination in COVID-19 Vaccines

Regulators previously said that they would not pull the Pfizer-BioNTech and Moderna COVID-19 vaccines from the market.

The U.S. Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The Food and Drug Administration is mulling over conducting its own evaluation of the levels of DNA in COVID-19 vaccines, an FDA official has disclosed.

“I'll say that that is something that’s being discussed,” Dr. Tracy Hoeg, a senior adviser to the FDA’s commissioner, told members of the Centers for Disease Control and Prevention’s vaccine advisory panel on Sept. 19.